250 participants: scientists and entrepreneurs, 3 days of debates and meetings on the most important challenges in the area of health and innovation in Europe, including representatives of Celon Pharma. The biggest meeting of this year was aimed at developing the main pillars of the EIT Health agenda in 2018/2019.
Jerzy Pieczykolan, PhD, Head of the Preclinical Research Department: Currently, as part of the EIT, our team is actively involved in projects whose aim is to train experts in the area of health, biotechnology and pharmacy, i.e. the areas which best implement the mission designated to EIT Health by the European Commission, i.e. supporting a healthy lifestyle and active ageing.
Maciej Wieczorek, PhD, President of the Board of Celon Pharma S.A.: We are happy that we, as a company, can participate in pan-European educational projects in the area of biopharmacy. It gives us the opportunity to exchange experiences with various international entities and expert circles with which we work closely within the EIT.
The European Institute of Innovation and Technology (EIT) is the European Union's agenda supporting the cooperation of enterprises, the education sector and research centres, which aims to create a favourable environment for innovation and entrepreneurship in Europe. Celon Pharma S.A. has been a member of the EIT since 2017.